JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (12): 57-61.doi: 10.6040/j.issn.1671-7554.0.2015.901

Previous Articles     Next Articles

Association between receptor of advanced glycation end products gene polymorphisms, soluble receptor of advanced glycation end products and susceptibility of type 2 diabetes mellitus

LI Fang   

  1. Department of Preventive Medicine, Jinan Central Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China
  • Received:2015-09-23 Online:2015-12-10 Published:2015-12-10

PDF (PC)

215

Abstract: Objective To estimate the level of soluble receptor of advanced glycation end product (sRAGE) in type 2 diabetes mellitus, as well as its association with single nucleotide polymorphism (SNP) of receptor of advanced glycation end product (RAGE). Methods A total of 184 patients with type 2 diabetes mellitus and 190 healthy controls were recruited. ELISA was applied to test sRAGE, and PCR-TaqMan-MGB probe was used for the genotyping of rs2070600, rs1800624, rs1800625 and rs184003. Results The level of sRAGE[M(P25,P75)] in type 2 diabetes mellitus patients was[1087.4(713.5,1213.4) pg/mL], which was significantly higher than that of the controls[908.2(674.6,1107.1 pg/mL)]. As to the allele analysis, no significant differences were observed in the minor allele frequency comparisons of the 4 SNPs, and no association was found between the 4 SNPs and sRAGE level in the linear regression. Conclusion The elevated level of sRAGE is associated with type 2 diabetes mellitus, but the polymorphism of RAGE is not. There is no significant association between polymorphism of SNPs in RAGE and sRAGE level.

Key words: Single nucleotide polymorphism, Type 2 diabetes mellitus, Soluble receptor for advanced glycation end products, Receptor for advanced glycation end products

CLC Number: 

  • R589
[1] Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-959.
[2] Maiese K, Morhan SD, Chong ZZ. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus[J]. Curr Neurovasc Res, 2007, 4(1):63-71.
[3] Santilli F, Vazzana N, Bucciarelli LG, et al. Soluble forms of RAGE in human diseases:clinical and therapeutical implications[J]. Curr Med Chem, 2009, 16(8):940-952.
[4] Niu W, Qi Y, Wu Z, et al. A meta-analysis of receptor for advanced glycation end products gene:four well-evaluated polymorphisms with diabetes mellitus[J]. Mol Cell Endocrinol, 2012, 358(1):9-17.
[5] Ng ZX, Kuppusamy UR, Iqbal T, et al. Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy[J]. Gene, 2013, 521(2):227-233.
[6] Gaens KH, Ferreira I, van der Kallen CJ, et al. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels[J]. J Clin Endocrinol Metab, 2009, 94(12):5174-5180.
[7] Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7):539-553.
[8] Schlueter C, Hauke S, Flohr AM, et al. Tissue-specific expression patterns of the RAGE receptor and its soluble forms-a result of regulated alternative splicing?[J]. Biochim Biophys Acta, 2003, 1630(1):1-6.
[9] Schmidt AM, Yan SD, Wautier JL, et al. Activation of receptor for advanced glycation end products:a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis[J]. Circ Res, 1999, 84(5):489-497.
[10] Nakamura K, Yamagishi S, Adachi H, et al. Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease[J]. Diabetes Metab Res Rev, 2007, 23(5):368-371.
[11] Tan KC, Shiu SW, Chow WS, et al. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes[J]. Diabetologia, 2006, 49(11):2756-2762.
[12] Challier M, Jacqueminet S, Benabdesselam O, et al. Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes[J]. Clin Chem, 2005, 51(9):1749-1750.
[13] Yamagishi S, Matsui T, Nakamura K. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes[J]. Curr Drug Targets, 2007, 8(10):1138-1143.
[14] Basta G, Sironi AM, Lazzerini G, et al. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein[J]. J Clin Endocrinol Metab, 2006, 91(11):4628-4634.
[15] Thomas MC, Woodward M, Neal B, et al. The relationship between levels of advanced glycation end-products and their soluble receptor and adverse outcomes in adults with type 2 diabetes[J]. Diabetes Care, 2015[Epub ahead of print]. doi:10.2337/dc15-0925.
[16] Forbes JM, Soderlund J, Yap FY, et al. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes[J]. Diabetologia,2011, 54(5):1032-1042.
[17] Lu W, Feng B. The-374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes:a meta-analysis[J]. Tohoku J Exp Med, 2010, 220(4):291-297.
[18] 顾喆瑶,姚勇,谢田华,等. RAGE基因-429T>C多态性与无锡汉族人群糖尿病视网膜病变的相关性[J].中华眼视光学与视觉科学杂志, 2015, 17(2):81-85. GU Zheyao, YAO Yong, XIE Tianhua, et al. Correlation analysis of the-429T>C polymorphism of advanced glycation end products of the receptor gene and type 2 diabetic retinopathy in Han people in the Wuxi area[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2015, 17(2):81-85.
[19] Haldar SR, Chakrabarty A, Chowdhury S, et al. Oxidative stress-related genes in type 2 diabetes:association analysis and their clinical impact[J]. Biochem Genet, 2015, 53(4-6):93-119.
[20] Kang P, Tian C, Jia C. Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy[J]. Gene, 2012, 500(1):1-9.
[21] Bansal S, Chawla D, Banerjee BD, et al. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients[J]. Gene, 2013, 526(2):325-330.
[22] Wu TL, Tsai CC, Wang YY, et al. The association between the RAGE G82S polymorphism, sRAGE and chronic periodontitis in Taiwanese individuals with and without diabetes[J]. J Periodontal Res, 2015[Epub ahead of print] doi:10.1111/jre.12282.
[23] Jang Y, Kim JY, Kang SM, et al. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans[J]. Metabolism, 2007, 56(2):199-205.
[1] MENG Zhaotun, LI Qin, SUN Hui, WU Xinfang, SUN Wenkai, GAO Wei. Correlation between interleukin-18 single nucleotide polymorphism and susceptibility of laryngeal squamous cell carcinoma: a report of 73 cases [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 58-63.
[2] DU Jinge, CHEN Hui, YANG Xiaorong, LÜ Ming. Meta-analysis of the association between the STAT4 rs7574865 polymorphism and systemic lupus erythematosus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 95-102.
[3] LI Shuai, WANG Yalin, SUN Zhongwen, ZHU Meijia. Expression changes and mechanism of Nod-like receptor protein 3 inflammasome in the cerebral microvascular endothelial cells in type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 6-11.
[4] PENG Li, QIANG Ye, ZHAO Huichen, CHEN Shihong, YAO Weidong, LIU Yuantao. Clinical studies on type 2 diabetic patients treated with sitagliptin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 60-63.
[5] LIN Dong, GUAN Qingbo. Association of serum testosterone level and non-alcoholic fatty liver disease in male patients with T2DM [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 33-37.
[6] Muhadasi TUERXUNYIMING, Patamu MOHEMAITI, Tuolanguli MAIMAITIKUERBAN. Association of CDKAL1 rs10946398 C/A polymorphism with type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 75-85.
[7] YU Ning, GAO Yanyan, XIAN Yuxin, NIU Jiapeng, LI Li, WANG Jing, CAO Caixia. Effect of exenatide on serum chemerin level and liver fat contents in type 2 diabetes mellitus combined with non-alcoholic fatty liver disease patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 51-55.
[8] LIU Yanxun, LIU Jia, ZHANG Tao, WANG Lu, XUE Fuzhong, WANG Ping. Type 2 diabetes mellitus associated with thyroid nodules: a longitudinal health check-up cohort study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(8): 83-86.
[9] PEI Leilei, SUN Zhonghua, LI Zhe, ZHAO Wenping. Effects of sitagliptin combined with high-dose insulin on type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 39-42.
[10] HU Fangzhi, ZHANG Zhengjun, GENG Houfa, LIANG Qiuhua, SUN Lin. Relationship between microalbuminuria and brain damage in patients with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 43-47.
[11] LI Hanbing, GAO Yanyan, LI Li, CAO Caixia, XIAN Yuxin, WANG Jing, NIU Jiapeng. Effect of lansoprazole and exenatide on gastrin and oxyntomodulin in patients with type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(11): 64-68.
[12] ZHANG Nan1, YUAN Zhongshang2, ZHANG Xu1, ZHANG Yikun1, YU Chunxiao1, GAO Ling3, ZHAO Jiajun1, GUAN Qingbo1, GUAN Liying4. Association between serum testosterone and lipid profile in men with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 58-61.
[13] BAI Yang1, CUI Guo-zhong1, DAI Dian-lu1, SANG Mei-xiang2, GENG Cui-zhi3. Association between Bax polymorphism and clinicopathologicalfeatures of breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(1): 71-74.
[14] YAN Qian1, LU Yan-qiang2, LI Ying2, SHI Chun-hong1, JIANG Ling1, YU Chuan-ting1. Polymorphisms of MTHFR and MTRR in women of Chinese Han population in Yantai city [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(1): 79-84.
[15] GUO Ya-di, GAO Yan-yan, LI Li, SUN Rui-xia, WANG Jing, XIAN Yu-xin. Effects of lansoprazole therapy on the plasma glucose and gastrin in the patients with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(7): 62-66.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd